---
title: "Biogen (BIIB) stock value data"
description: "Biogen (BIIB) value data from SEC filings and the recent price, as of 2026-09-19."
canonical_url: https://trendshare.org/stocks/BIIB/view
markdown_url: https://trendshare.org/ai/stocks/BIIB.md
data_as_of: 2026-09-19
source: SEC EDGAR company facts (annual 10-K data)
content_license: https://trendshare.org/about/disclaimer
---
# Biogen (BIIB)

Source: https://trendshare.org/stocks/BIIB/view
Data as of: 2026-09-19

## Key facts

- Exchange: NasdaqGS
- Current price: $215.50
- Sector: Healthcare
- Industry: Biotechnology

## Value estimates

- Estimated fair value per share: $248.28
- Estimated safe value per share: $198.62
- Price discount to estimated fair value: none

## Cash flow

- Average free cash flow growth rate: 4%
- Free cash flow variability: 20%

## Notes

These are automated calculations from annual SEC filings (10-K data) and the recent price. They are not a recommendation to buy or sell. The stock page explains the method: https://trendshare.org/stocks/BIIB/view. Full disclaimer: https://trendshare.org/about/disclaimer